Search Results 351-360 of 19555 for autoimmune hepatitis
Alfonso (Sebastian) S. Lopez Chiriboga, M.D., and Iris (Vanessa) V. Marin Collazo, M.D., discuss autoimmune neurology, one of neurology's most rapidly ...
The imaging biomarkers will cover an array of methods that could be applicable to non-alcoholic fatty liver disease (NAFLD), including liver fat, liver ...
chronic liver disease, including autoimmune, viral, metabolic, or alcoholic liver disease. - Clinical evidence of compensated or decompensated hepatic ...
Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is common ...
Nonalcoholic fatty liver disease (NAFLD) and the ... Expanding the donor pool and improved utilization of Hepatitis C grafts in both liver and non-liver ...
Learn how to spot and what to do if you experience signs of this serious liver disease complication.
Recent preliminary data have suggested that HBV-HCC may be more responsive to immunotherapy than are cancers associated with other forms of liver disease.
Liver transplant, Primary sclerosing cholangitis, Autoimmune hepatitis, Primary biliary cholangitis, Hepatic encephalop...athy. Show more areas of focus for ...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...
In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021.https://www.clinicalkey ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.